SOT 2025—A 13-Week Dermal Tox Study of VIM-004 Topical Star Particles in Göttingen Minipigs®

Presented by Ahmed Abdalla, PhD, Scientist/Study Director, Safety Assessment, at the 64ᵗʰ Annual Annual Meeting and ToxExpo in Orlando, FL. Altasciences is an integrated drug development solution company, offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. From lead candidate selection to proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing and analytical services. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. Altasciences… helping sponsors get better drugs to the people who need them, faster. Visit our website to learn more: https://www.altasciences.com/